Yunping Song

Dr. Yunping Song

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
JHJiehong Huang
Jiehong Huang
RLRuoyu Li
Ruoyu Li
LLLixi Li
Lixi Li
YSYunping Song
Yunping Song
LJLingjing Jin
Lingjing Jin

1 June 2010 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YSYunping Song
Yunping Song
FSFriedrich Schlesinger
Friedrich Schlesinger
DRDaniela Ragancokova
Daniela Ragancokova
RCRoger Calixto
Roger Calixto
RDReinhard Dengler
Reinhard Dengler
KKKlaus Krampfl
Klaus Krampfl

1 October 2024 in Neurochemistry International
Verified
Journal Article
Open access
WCWen Cheng
Wen Cheng
KFKexin Fang
Kexin Fang
XOXiaorong Ouyang
Xiaorong Ouyang
LJLingjing Jin
Lingjing Jin
YSYunping Song
Yunping Song
BYBin Yu
Bin Yu
Parkinson's disease (PD) is a common neurodegenerative disease characterized by the loss of dopaminergic (DA) neurons in the substantia nigra (SN). Conventional treatments are ineffective in reversing disease progression. Recently, the therapeutic and rehabilitation potential of vagus nerve stimulation (VNS) in PD has been explored. However, the underlying mechanisms remain largely unknown. In this study, we investigated the neuroprotective effects of VNS in a lateral lesioned mice model of PD. Excluding controls, experimental mice received cuff electrode implantation on the left vagus nerve and 6-hydroxydopamine administration into the bilateral striatum. After ten days, electrical stimulation was delivered for 11 consecutive days onto PD animals. Behavioral tests were performed after stimulation. The expression of TH, Iba-1, GFAP, adrenergic receptors and cytokines in the SN and striatum was detected by immunofluorescence or western blotting. The activity of noradrenergic neurons in the locus coeruleus (LC) was also measured. Our results suggest that VNS improved behavioral performance in rod rotation, open field tests and pole-climbing tests in PD mice, accompanied by a decrease in the loss of dopaminergic neurons in the SN and increased TH expression in the striatum. Neuroinflammation-related factors, such as GFAP, Iba-1, TNF-α and IL-1β were also suppressed in PD mice after VNS compared to those without treatment. Furthermore, the proportion of c-Fos-positive noradrenergic neurons in the LC increased when animals received VNS. Additionally, the expression of the adrenergic receptor of α1BR was also upregulated after VNS compared to PD mice. In conclusion, VNS has potential as a novel PD therapy for neuroprotective effects, and indicate that activation of norepinephric neurons in LC may plays an important role in VNS treatment for PD.

31 May 2025 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
HYHongkai Yao
Hongkai Yao
CLChenming Liu
Chenming Liu
LJLingjing Jin
Lingjing Jin
YSYunping Song
Yunping Song

30 September 2025 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
KZKaige Zhou
Kaige Zhou
JZJingxing Zhang
Jingxing Zhang
JSJunhui Su
Junhui Su
WTWeifang Tong
Weifang Tong
RLRuoyu Li
Ruoyu Li
YSYunping Song
Yunping Song
Alzheimer’s disease (AD) and Parkinson’s disease (PD) share neuroinflammatory features, yet their common immune-related mechanisms remain unclear. We integrated microarray datasets from AD/PD brain tissues to identify immune-related genes (IRGs). Hub genes were prioritized via protein-protein interaction (PPI) networks and validated using a Parkinson’s dementia (PDD) cohort and AD/PD mouse models. Functional enrichment, immune cell infiltration, and TF-miRNA networks were analyzed. Eleven hub IRGs (CXCR4, FLT1, SLIT1/2, SEMA3G/6D, etc.) were identified. CXCR4 and FLT1 exhibited significant upregulation in AD/PD patient brain tissues (AUC > 0.7, adjusted p-value of <0.05) and mouse model brain tissues (p < 0.05), correlating with cytokine signaling and axon guidance pathways. CXCR4 is uniquely associated with resting memory CD4+ T cells in both diseases, while FLT1 showed disease-specific immune interactions. A TF-miRNA network (39 TFs, 22 miRNAs) implicated CREB1 and STAT1/3 as key regulators. CXCR4 and FLT1 are pivotal shared immune hubs in AD/PD, linked to T-cell dysregulation and neuroinflammation. These findings highlight potential therapeutic targets and biomarkers for neurodegenerative comorbidity.

1 January 2025 in Behavioural Neurology
Verified
Journal Article
Open access
YBYunjun Bao
Yunjun Bao
RHRonghua Hong
Ronghua Hong
WQWenting Qin
Wenting Qin
ZWZhuang Wu
Zhuang Wu
YSYunping Song
Yunping Song
LJLingjing Jin
Lingjing Jin
Neurological disorders frequently result in diverse forms of abnormal movement. Conventional clinical assessment approaches often lack the precision and objectivity needed to evaluate muscle involvement and associated functional limitations. With the development of various intelligent assessment devices, technologies such as wearable sensors, motion capture, radar, and imaging technology, which are based on myoelectricity, kinematics, mechanics, and optics, combined with mathematical models and algorithms, have been widely used for abnormal movement recognition. These technologies further improve the accuracy and validity of clinical evaluation. In this paper, we review the latest advances in intelligent technologies that help clinicians qualitatively and quantitatively assess abnormal movement patterns and carry out personalized rehabilitation treatment. Our work was also aimed at summarizing the research and application of intelligent assessment techniques.